Aegon Ltd., the Dutch-American insurance and financial services group listed on both Euronext Amsterdam and the New York Stock Exchange, has announced a sweeping corporate restructuring that will see it abandon its Netherlands domicile and re-emerge as a fully American company by January 1, 2028.
The move, branded internally as "The Next Frontier" and unveiled at the company's Capital Markets Day in December 2025, will culminate in the group renaming itself Transamerica Inc. — a nod to its dominant US subsidiary, which already generates roughly 70% of total group operations. Shareholders will be asked to approve the plan at an Extraordinary General Meeting scheduled for Q4 2026.
The Strategic Rationale
The redomiciliation is less a surprise than an acknowledgment of commercial reality. Transamerica, Aegon's US life insurance and retirement services arm, generated an operating result of USD 1.4–1.6 billion on a 2025 run-rate basis. Its distribution network through World Financial Group (WFG) spans more than 92,000 independent agents, targeting annuity sales of USD 5.0 billion and life sales of USD 900 million by 2027.
Against that backdrop, maintaining a European legal domicile — and navigating dual regulatory frameworks across EU Solvency II, Bermuda solvency requirements, and US state insurance regulation — added structural complexity with diminishing strategic benefit. A single US domicile consolidates regulatory oversight under American supervisors and aligns the corporate structure with where cash is actually generated.
Tax and Regulatory Implications
The shift carries significant implications for corporate tax strategy. Moving the legal seat to the US subjects Aegon's global holding structure to US federal corporate tax, but also enables more straightforward capital deployment from US subsidiaries to a US parent — eliminating withholding friction that European holding structures can impose on cross-border remittances.
The group will transition to US GAAP reporting starting with full-year 2027 results, abandoning IFRS — a material change that will alter how investors read balance sheet strength, reserve adequacy, and earnings quality. To manage market expectations during the transition, Aegon is suspending quarterly trading updates between 2026 and 2027, limiting disclosure to half-year reporting only.
Implementation Costs and Capital Management
The restructuring carries an implementation price tag of EUR 350 million, spread across the second half of 2025 through the first half of 2028. Despite that outlay, management is simultaneously running a EUR 400 million share buyback program starting January 2026, split evenly across the two halves of the year — a signal of confidence in free cash flow generation, targeted at EUR 0.8 billion per year growing at 5% annually.
Dividend guidance of EUR 0.40 per share for 2025, growing at more than 5% annually, remains intact through the transition.
Parallel Moves
The redomiciliation is not Aegon's only structural change underway. The company has initiated a strategic review of Aegon UK, with divestment explicitly cited as one option under evaluation. It has also executed a reinsurance transaction covering USD 10 billion in net face value of Secondary Guarantee Universal Life (SGUL) contracts — addressing 80% of that legacy portfolio — freeing up capital and enabling USD 75 million in additional annual remittances to the holding company.
Aegon's largest shareholder, Vereniging Aegon, has stated it views the US relocation positively and will constructively review the proposals put to the EGM. That institutional backing reduces the risk of a shareholder revolt complicating the timeline.
When the transition closes, a 180-year-old Dutch institution will have fully reinvented itself as an American financial services company — one of the more significant corporate identity shifts in European insurance history.